PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 117 filers reported holding PROVENTION BIO INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $170,177 | +107.5% | 16,100 | -12.0% | 0.00% | +100.0% |
Q3 2022 | $82,000 | +12.3% | 18,300 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $73,000 | -45.1% | 18,300 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $133,000 | +30.4% | 18,300 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $102,000 | -12.8% | 18,300 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $117,000 | -24.0% | 18,300 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $154,000 | -19.8% | 18,300 | 0.0% | 0.00% | -33.3% |
Q1 2021 | $192,000 | -38.9% | 18,300 | -1.5% | 0.00% | -57.1% |
Q4 2020 | $314,000 | +24.6% | 18,575 | -5.5% | 0.01% | +16.7% |
Q3 2020 | $252,000 | -9.0% | 19,650 | 0.0% | 0.01% | -25.0% |
Q2 2020 | $277,000 | +40.6% | 19,650 | -8.0% | 0.01% | 0.0% |
Q1 2020 | $197,000 | -66.0% | 21,370 | -45.0% | 0.01% | -65.2% |
Q4 2019 | $579,000 | +113.7% | 38,870 | -2.3% | 0.02% | +64.3% |
Q3 2019 | $271,000 | -24.1% | 39,770 | +34.6% | 0.01% | -30.0% |
Q2 2019 | $357,000 | +485.2% | 29,550 | +10.3% | 0.02% | +400.0% |
Q1 2019 | $61,000 | +29.8% | 26,800 | 0.0% | 0.00% | -20.0% |
Q4 2018 | $47,000 | – | 26,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sessa Capital IM, L.P. | 6,000,000 | $43,920,000 | 2.10% |
VR Adviser, LLC | 1,118,653 | $8,189,000 | 1.33% |
DG Capital Management, LLC | 522,568 | $3,825,000 | 0.77% |
Atom Investors LP | 42,680 | $312,000 | 0.15% |
ADVISORY RESEARCH INC | 235,000 | $1,720,000 | 0.14% |
Perceptive Advisors | 791,549 | $5,794,000 | 0.12% |
Verition Fund Management LLC | 1,086,593 | $7,954,000 | 0.10% |
Virtus ETF Advisers LLC | 26,467 | $194,000 | 0.09% |
1900 WEALTH MANAGEMENT LLC | 95,555 | $699,000 | 0.07% |
RICE HALL JAMES & ASSOCIATES, LLC | 220,065 | $1,611,000 | 0.06% |